Skip to main content

International Lung Screen Trial (ILST)

The International Lung Screen Trial (ILST) aims to establish the optimal selection criteria for low-dose computed tomography screening of individuals at high risk for developing lung cancer, and to evaluate the PanCan model for managing screen-detected nodules.


Stephen Lam discusses the interim findings from the ILST indicating that changing eligibility criteria can improve identification of high-risk individuals (5:36):

The interim results were presented at WCLC 2019:

Title: Lung cancer screenee selection by USPSTF versus PLCOm2012 criteria – interim ILST findings
Presenter: Stephen Lam, University of British Columbia, Vancouver, Canada
Monday, September 9: 08:15–08:25 (Abstract PL02.02)

Back to the WCLC 2019 conference hub